Using quetiapine to help veterans with post concussive syndrome after mild brain injuries
Official title: A Randomized Clinical Trial of Quetiapine to Reduce Post Concussive Syndrome Polypharmacy
Run by Foundation for Advancing Veterans' Health Research · NCT06333990 · Data updated 2026-11-12
This study tests if the medication quetiapine can help veterans aged 18-65 recover from post concussive syndrome after mild brain injuries better than standard treatments.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 146 (estimated) |
| Sponsor | Foundation for Advancing Veterans' Health Research Academic / other |
| Locations | 2 sites (Albuquerque, New Mexico and 1 other locations) |
| Status | Recruiting |
| Started | July 9, 2024 |
| Main results expected | June 2028 |
| Study ends | June 2028 |
| Registry record updated | July 11, 2025 |
| Trial ID | NCT06333990 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are male or female veterans aged 18-65 with a diagnosis of mild traumatic brain injury and post concussive syndrome symptoms.
✕Probably not a fit
Patients with moderate or severe traumatic brain injury or major psychiatric disorders such as schizophrenia or bipolar disorder may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This Phase III clinical trial evaluates the effectiveness of quetiapine monotherapy compared to standard treatment for veterans experiencing post concussive syndrome following mild traumatic brain injury. The study involves two sites and focuses on veterans aged 18-65 who have been stable on multiple psychotropic medications. Participants will be assessed for their symptoms using established inventories to determine the impact of quetiapine on their recovery.
Why it matters
Potential benefit: If successful, this treatment could significantly alleviate symptoms of post concussive syndrome in veterans, improving their quality of life.
How similar studies have gone: Other studies have explored the use of quetiapine for various psychiatric conditions, but this specific application for post concussive syndrome in veterans is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Male or female veterans seeking treatment for mTBI, aged 18-65 years 2. Meet mTBI diagnosis and have PCS symptoms reported on the Neurobehavioral Symptom Inventory (NSI). Six months or more must elapse between the injury and Screening. mTBI diagnosis will be determined using the provisional diagnostic convention recommended by the VA/DoD requiring loss of consciousness, or a period of altered consciousness, or posttraumatic amnesia; 3. Be stable (i.e., no dose changes for \> 1 month) on at least three CNS active psychotropic medications prescribed for symptom relief or psychiatric treatment. 4. Have posttraumatic symptoms measured by PTSD Checklist for DSM-5 (PCL-5) score ≥25. Exclusion Criteria: 1. Moderate or severe TBI, or major neurocognitive disorder (dementia). 2. Meet DSM-5 criteria for schizophrenia, bipolar disorder, schizoaffective disorder, or requiring inpatient hospitalization currently or within past 6 months. 3. Currently taking any antipsychotics or prohibited medication within the past month . 4. Known intolerance to quetiapine or a history of clinically unstable heart, lung, liver, renal, hematological, or endocrinological condition, diabetes mellitus, severe sleep apnea and/or seizure disorder. 5. Substance use disorder severe enough to require medication treatment or medical detoxification or inpatient hospitalization within 6 months of screening. 6. Reporting suicidal ideation of type 4 or 5 in the Columbia Suicide Severity Rating Scale (CSSRS) in the past 3 months prior to screening or at screening or baseline visit (i.e. active suicidal thought with method and intent but without specific plan, or active suicidal thought with method, intent, and plan); or homicidal ideation with intent or plan to harm others within 90 days or suicide attempt; or suicidal behavior within 6 months prior to screening. (Note: Study psychiatrist will be immediately notified when SI or HI intent is positive) 7. Current or known history of cardiac arrhythmia or QTc interval ≥ 470 milliseconds. 8. Pregnant or lactating women and those of child-bearing potential not using a reliable method of contraception will be excluded from participating in the study.
Where it's running
-
New Mexico VA Healthcare System
Albuquerque, New Mexico, United States Recruiting -
South Texas Veterans Healthcare System
San Antonio, Texas, United States Recruiting
Study contacts
- Study coordinator: Muhammad R Baig, MD
- Email: muhammad.baig@va.gov
- Phone: 210-617-5300
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Recovery after mild traumatic brain injury in older adults
This project will follow people 65 and older who had a mild TBI to see how their thinking, physical abilities, mood, and sleep change over the year after injury.
-
TES HT100 screening for intracranial problems after mild head injury or new neurological symptoms
This test checks if the TES HT100 can quickly and safely find intracranial problems in adults who come to the emergency department with mild head injury or new non‑traumatic neurological symptoms.
-
Two online brain-training programs to help emotional health after mild TBI
This study tests two remote brain-training programs to see which better improves emotional health in adults with mild traumatic brain injury and alexithymia.
-
Cognitive behavioral therapy for insomnia in people with mild traumatic brain injury
This study will try cognitive behavioral therapy for insomnia (CBT-I) to see if it helps adults with mild traumatic brain injury sleep better and improve daily functioning.
-
Passive neurosensory reintegration training to help recovery after mild traumatic brain injury
We will try a gentle multisensory therapy called passive neurosensory reintegration training (PNRT) to see if it helps adults with sub-acute or chronic mild traumatic brain injury recover neurosensory and cognitive symptoms.
-
Early Intervention for Adults with Ongoing Post-Concussion Symptoms after Mild TBI
This study tests a package of physical/occupational therapy and telephonic psychoeducation to help adults recover after a mild traumatic brain injury.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.